Literature DB >> 15720803

Early neoplastic progression is complement independent.

Karin E de Visser1, Lidiya V Korets, Lisa M Coussens.   

Abstract

Infiltration of leukocytes into premalignant tissue is a common feature of many epithelial neoplasms and is thought to contribute to cancer development. However, the molecular and cellular regulatory mechanisms underlying activation of innate host responses to enhanced neoplastic cell proliferation are largely unknown. Considering the importance of the complement system in regulating inflammation during acute pathologic tissue remodeling, we examined the functional significance of complement component 3 (C3) as a regulator of inflammatory cell infiltration and activation during malignant progression by using a transgenic mouse model of multistage epithelial carcinogenesis, e.g., HPV16 mice. Whereas abundant deposition of C3 is a characteristic feature of premalignant hyperplasias and dysplasias coincident with leukocyte infiltration in neoplastic tissue, genetic elimination of C3 neither affects inflammatory cell recruitment toward neoplastic skin nor impacts responding pathways downstream of inflammatory cell activation, e.g., keratinocyte hyperproliferation or angiogenesis. Taken together, these data suggest that complement-independent pathways are critical for leukocyte recruitment into neoplastic tissue and leukocyte-mediated potentiation of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15720803      PMCID: PMC1531681          DOI: 10.1593/neo.04250

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  55 in total

1.  B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity.

Authors:  Marian Szczepanik; Moe Akahira-Azuma; Krzysztof Bryniarski; Ryohei F Tsuji; Ivana Kawikova; Wlodzimierz Ptak; Claudia Kiener; Regis A Campos; Philip W Askenase
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

2.  C3a and C5a stimulate chemotaxis of human mast cells.

Authors:  K Hartmann; B M Henz; S Krüger-Krasagakes; J Köhl; R Burger; S Guhl; I Haase; U Lippert; T Zuberbier
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

3.  Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

Authors:  L A García-Rodríguez; C Huerta-Alvarez
Journal:  Epidemiology       Date:  2001-01       Impact factor: 4.822

Review 4.  Chronic inflammation and cancer.

Authors:  Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2002-02       Impact factor: 2.990

5.  Nonsteroidal anti-inflammatory drug use and breast cancer risk.

Authors:  M Cotterchio; N Kreiger; M Sloan; A Steingart
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

6.  Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity.

Authors:  Michaela Robbie-Ryan; Melinda B Tanzola; Virginia H Secor; Melissa A Brown
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

7.  Immune enhancement of skin carcinogenesis by CD4+ T cells.

Authors:  Dylan Daniel; Nicole Meyer-Morse; Emily K Bergsland; Kerstin Dehne; Lisa M Coussens; Douglas Hanahan
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

8.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

Authors:  Antonio González-Pérez; Luis A García Rodríguez; Ruy López-Ridaura
Journal:  BMC Cancer       Date:  2003-10-31       Impact factor: 4.430

9.  Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.

Authors:  K Akre; A M Ekström; L B Signorello; L E Hansson; O Nyrén
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

10.  Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression.

Authors:  J Boesiger; M Tsai; M Maurer; M Yamaguchi; L F Brown; K P Claffey; H F Dvorak; S J Galli
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  15 in total

1.  Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Authors:  Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise Bruyére; Philippe Delvenne; Marlene Tacke; Thomas Reinheckel; Jean-Michel Foidart; Lisa M Coussens; Agnès Noël
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

2.  B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.

Authors:  Nesrine I Affara; Brian Ruffell; Terry R Medler; Andrew J Gunderson; Magnus Johansson; Sophia Bornstein; Emily Bergsland; Martin Steinhoff; Yijin Li; Qian Gong; Yan Ma; Jane F Wiesen; Melissa H Wong; Molly Kulesz-Martin; Bryan Irving; Lisa M Coussens
Journal:  Cancer Cell       Date:  2014-06-05       Impact factor: 31.743

3.  FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

Authors:  Pauline Andreu; Magnus Johansson; Nesrine I Affara; Ferdinando Pucci; Tingting Tan; Simon Junankar; Lidiya Korets; Julia Lam; David Tawfik; David G DeNardo; Luigi Naldini; Karin E de Visser; Michele De Palma; Lisa M Coussens
Journal:  Cancer Cell       Date:  2010-02-04       Impact factor: 31.743

Review 4.  Three-dimensional context regulation of metastasis.

Authors:  Janine T Erler; Valerie M Weaver
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

5.  Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.

Authors:  Terry R Medler; Dhaarini Murugan; Wesley Horton; Sushil Kumar; Tiziana Cotechini; Alexandra M Forsyth; Patrick Leyshock; Justin J Leitenberger; Molly Kulesz-Martin; Adam A Margolin; Zena Werb; Lisa M Coussens
Journal:  Cancer Cell       Date:  2018-10-08       Impact factor: 31.743

6.  C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.

Authors:  William D Jackson; Alessandro Gulino; Liliane Fossati-Jimack; Rocio Castro Seoane; Kunyuan Tian; Katie Best; Jörg Köhl; Beatrice Belmonte; Jessica Strid; Marina Botto
Journal:  J Invest Dermatol       Date:  2020-07-16       Impact factor: 8.551

Review 7.  Humoral innate immune response and disease.

Authors:  Stephanie N Shishido; Sriram Varahan; Kai Yuan; Xiangdong Li; Sherry D Fleming
Journal:  Clin Immunol       Date:  2012-06-18       Impact factor: 3.969

8.  Loss of the α2β1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro.

Authors:  Thuy Tran; Brittney Barlow; Lynda O'Rear; Brenda Jarvis; Zhengzhi Li; Kent Dickeson; William Dupont; Mary Zutter
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

9.  Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression.

Authors:  Elena Magrini; Sabrina Di Marco; Sarah N Mapelli; Chiara Perucchini; Fabio Pasqualini; Alessia Donato; Maria de la Luz Guevara Lopez; Roberta Carriero; Andrea Ponzetta; Piergiuseppe Colombo; Ferdinando Cananzi; Domenico Supino; Edimara S Reis; Clelia Peano; Antonio Inforzato; Sebastien Jaillon; Andrea Doni; John D Lambris; Alberto Mantovani; Cecilia Garlanda
Journal:  Nat Cancer       Date:  2021-02-18

10.  Modulation of the antitumor immune response by complement.

Authors:  Maciej M Markiewski; Robert A DeAngelis; Fabian Benencia; Salome K Ricklin-Lichtsteiner; Anna Koutoulaki; Craig Gerard; George Coukos; John D Lambris
Journal:  Nat Immunol       Date:  2008-09-28       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.